Cormorant Asset Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-896,600
| Closed | -$2.41M | – | 98 |
|
|
2016
Q1 | $2.41M | Hold |
896,600
| – | – | 0.36% | 60 |
|
|
2015
Q4 | $2.77M | Hold |
896,600
| – | – | 0.33% | 55 |
|
|
2015
Q3 | $3.96M | Hold |
896,600
| – | – | 0.63% | 43 |
|
|
2015
Q2 | $5.12M | Hold |
896,600
| – | – | 0.68% | 41 |
|
|
2015
Q1 | $8.03M | Buy |
896,600
+821,600
| +1,095% | +$7.35M | 1.24% | 24 |
|
|
2014
Q4 | $425K | Buy |
+75,000
| New | +$425K | 0.07% | 66 |
|